John Fluevog to speak at 2026 American Transplant Congress

6 hours ago
John Fluevog to speak at 2026 American Transplant Congress

John Fluevog, founder of John Fluevog Shoes and a kidney transplant recipient, will appear at the American Transplant Congress 2026 in Boston to share his transplant story and spotlight living donation. The appearance ties a patient perspective to the field’s top annual meeting and supports a donor-inspired shoe collection that funds transplant advocacy and education.

Why it matters: - Fluevog’s appearance puts a patient and donor-recipient story in front of transplant professionals at the field’s premier annual meeting. - The event highlights the real-world impact of living donation and the ongoing need for more kidney donors. - The donor-inspired shoe collection also channels support to the American Society of Transplantation and its work in education, advocacy, research, and organ donation awareness.

What happened: - John Fluevog, founder of the globally recognized footwear brand John Fluevog Shoes, will appear at the American Transplant Congress 2026 in Boston. - Fluevog is a kidney transplant recipient. - ATC 2026 runs June 20-24, 2026, in Boston, Massachusetts. - Fluevog will take part in the AST Town Hall on Monday, June 22. - Fluevog will also meet attendees during the conference and share the story behind his kidney transplant and donor-inspired shoe collection.

The details: - The American Transplant Congress is the Joint Annual Meeting of the American Society of Transplantation and the American Society of Transplant Surgeons. - ATC brings together physicians, surgeons, scientists, nurses, organ procurement professionals, pharmacists and allied health professionals. - The meeting is positioned as the premier event for innovation and progress in transplantation. - Fifteen percent of sales from Fluevog’s donor-inspired collection support the American Society of Transplantation. - The collection was created in honor of Fluevog’s living donor. - Media attending ATC will have opportunities for interviews and photography related to Fluevog’s participation and the collection. - Press interested in attending or arranging interviews can contact Shauna O’Brien at sobrien@myAST.org. - More information about the meeting is available at the ATC website.

Between the lines: - The appearance blends advocacy, fundraising and public education into a patient-centered conference moment. - AST is using a recognizable creative figure to help broaden awareness of transplant needs beyond the clinical community. - Fluevog’s involvement gives the conference a personal narrative that could make the case for living donation more accessible to a wider audience.

What’s next: - Fluevog is expected to appear at ATC on June 22 and interact with attendees throughout the meeting. - The conference will continue through June 24 with sessions focused on transplantation science and patient care. - Media outreach and interview scheduling will run through the contacts listed by organizers.

The bottom line: - Fluevog’s ATC appearance turns a transplant success story into a platform for donor awareness, professional engagement and support for the transplant community.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.